Back
Stoneridge 10K Form
Sell
28
SRI
Stoneridge
Last Price:
6.62
Seasonality Move:
5.41%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-01 | 10Q | SRI/Stoneridge Quarterly |
2023-11-01 | 10Q | SRI/Stoneridge Quarterly |
2023-08-02 | 10Q | SRI/Stoneridge Quarterly |
2023-05-03 | 10Q | SRI/Stoneridge Quarterly |
2022-11-02 | 10Q | SRI/Stoneridge Quarterly |
2022-08-03 | 10Q | SRI/Stoneridge Quarterly |
Receive SRI News And Ratings
See the #1 stock for the next 7 days that we like better than SRI
SRI Financial Statistics
Sales & Book Value
Annual Sales: | $975.82M |
---|---|
Cash Flow: | $4.63M |
Price / Cash Flow: | 17.98 |
Annual Sales: | $9.80 |
Price / Book: | 0.68 |
Profitability
EPS (TTM): | -0.27000 |
---|---|
Net Income (TTM): | $-7.39M |
Gross Margin: | $201.31M |
Return on Equity: | -2.68% |
Return on Assets: | -1.1% |
Stoneridge Earnings Forecast
Key Stoneridge Financial Ratios
- The Gross Profit Margin over the past 28 years for SRI is 20.63%.
- The Selling, General & Administrative Expenses for SRI have been equal to 12.03% of Gross Profit Margin.
- The Research & Development expenses have been 7.28% of Revenue.
- The Interest Expense is -250.82% of Operating Income.
- The Net Earning history of SRI is -0.53% of Total Revenues.
- Per Share Earnings over the last 28 years have been positive in 16 years.
Stoneridge Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Automobile Components |
Sector: | Consumer Discretionary |
Current Symbol: | SRI |
CUSIP: | 86183P |
Website: | stoneridge.com |
Debt
Debt-to-Equity Ratio: | 0.72 |
---|---|
Current Ratio: | 2.44 |
Quick Ratio: | 1.25 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 66.2 |
SRI Technical Analysis vs Fundamental Analysis
Sell
28
Stoneridge (SRI)
is a Sell
Is Stoneridge a Buy or a Sell?
-
Stoneridge stock is rated a Sell
The current Stoneridge [SRI] share price is $6.62. The Score for SRI is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.